Kidd & Company, LLC Exits NextPhase Medical Devices, LLC

Kidd & Company, LLC (“KCO”), a leading family office investment firm focused on the lower middle market, is pleased to announce the sale of NextPhase Medical Devices, LLC (“NextPhase”) to Medical Device, Inc. (“Arterex”), a leading medical device contract manufacturer, indirectly invested in by Investindustrial Growth fund. Terms of the transaction were not disclosed. NextPhase is a class II and III medical device contract manufacturer of complex electromechanical devices, active implantable devices and single use disposables in North America. It provides design and engineering, manufacturing and assembly, quality and regulatory, and supply chain and logistics management services enabling its customers to bring low-to-medium volume complex medical devices to market.

KCO initiated its investment in NextPhase in 2015 through a control investment in Nexcore Technology, which was founded by Milton Frank in 1999 as a manufacturer of complex electromechanical medical devices to leading medical OEMs. Upon completion of the initial platform acquisition, KCO added Carlo Colesanti and James DiVizio as NextPhase’s CEO and CFO, respectively, as well as made several investments and enhancements to the initial platform through additions to people, processes and infrastructure. In 2017 Nexcore acquired Phase 2 Medical Manufacturing and rebranded as NextPhase Medical Devices as a premier provider of design, engineering, development and manufacturing of capital equipment and single-use disposable devices to leading and emerging medical device OEMs. In 2021, NextPhase acquired Proven Process Medical Devices to enhance its design and engineering capabilities and to add specific manufacturing expertise in new areas, such as implantable devices. Today NextPhase operates out of three North American facilities in New Hampshire, Massachusetts and Tijuana, Mexico. For more information, visit www.nextphasemed.com.

Ken Heuer, KCO principal and NextPhase Board member stated, “We have been honored to work with Carlo, Jim, and each of the previous business owners and their respective organizations over the last eight years to generate tremendous growth, jobs and prosperity for everyone involved. We set out with the goal of building a comprehensive supply chain partner to the top medical device manufacturers and could not be happier with what the team has been able to achieve.” Carlo Colesanti added, “We appreciate the experience and resources that KCO brought to bear on behalf of the business and are excited for the next stage of our growth.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy